Cancer feature: cnaPANCAN6

ACTL9 ADAMTS10 ANGPTL4 ANGPTL6 ARHGEF18 C19orf45 C19orf59 C19orf66 C19orf82 CAMSAP3 CCL25 CD209 CD320 CERS4 CLEC4G CLEC4M COL5A3 CTB-133G6.1 CTD-2207O23.10 CTD-2207O23.12 CTD-2207O23.3 CTD-3193O13.9 CTD-3214H19.16 CTD-3214H19.4 CTXN1 EIF3G ELAVL1 EVI5L FBN3 FBXL12 FCER2 HNRNPM KANK3 LRRC8E MAP2K7 MARCH2 MBD3L1 MCOLN1 MUC16 MYO1F NDUFA7 NDUFA7 OLFM2 OR1M1 OR2Z1 OR7D2 OR7D4 OR7E24 OR7G1 OR7G2 OR7G3 P2RY11 PCP2 PET100 PEX11G PIN1 PNPLA6 PPAN PPAN-P2RY11 PRAM1 RAB11B RDH8 RETN RPS28 SNAPC2 STXBP2 TGFBR3L TIMM44 TRAPPC5 UBL5 XAB2 ZNF121 ZNF177 ZNF266 ZNF317 ZNF358 ZNF414 ZNF426 ZNF558 ZNF559 ZNF559-ZNF177 ZNF560 ZNF561 ZNF562 ZNF699 ZNF812 ZNF846

Known Driver Genes: None

Copy number alternation: loss

Telomerase Inhibitor IX

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer